These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 23391869

  • 1. The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease.
    Margariti A, Deutsch M, Manolakopoulos S, Tiniakos D, Papatheodoridis GV.
    J Clin Gastroenterol; 2013 Mar; 47(3):280-6. PubMed ID: 23391869
    [Abstract] [Full Text] [Related]

  • 2. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [Abstract] [Full Text] [Related]

  • 3. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
    Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P, Elkashab M.
    J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
    [Abstract] [Full Text] [Related]

  • 4. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [Abstract] [Full Text] [Related]

  • 5. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ.
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [Abstract] [Full Text] [Related]

  • 6. Primary biliary cirrhosis is more severe in overweight patients.
    Híndi M, Levy C, Couto CA, Bejarano P, Mendes F.
    J Clin Gastroenterol; 2013 Mar; 47(3):e28-32. PubMed ID: 23059407
    [Abstract] [Full Text] [Related]

  • 7. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U, Yesil A, Yilmaz Y.
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [Abstract] [Full Text] [Related]

  • 8. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H, Gonzalez JL, Márquez-Ramirez MD, Flores-Hernandez M, Rodríguez-Morán M, Guerrero-Romero F.
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [Abstract] [Full Text] [Related]

  • 9. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
    Hossain N, Stepanova M, Afendy A, Nader F, Younossi Y, Rafiq N, Goodman Z, Younossi ZM.
    Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
    [Abstract] [Full Text] [Related]

  • 10. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL, Valenti L, Bugianesi E, Vanni E, Grieco A, Miele L, Consonni D, Fatta E, Lombardi R, Marchesini G, Fargion S.
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [Abstract] [Full Text] [Related]

  • 11. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC, Yang YJ.
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [Abstract] [Full Text] [Related]

  • 12. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease.
    Friis-Liby I, Aldenborg F, Jerlstad P, Rundström K, Björnsson E.
    Scand J Gastroenterol; 2004 Sep; 39(9):864-9. PubMed ID: 15513385
    [Abstract] [Full Text] [Related]

  • 13. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV, Goulis J, Christodoulou D, Manolakopoulos S, Raptopoulou M, Andrioti E, Alexandropoulos N, Savvidou S, Papachristou A, Zervou E, Seferiadis K, Kousidou P, Vogiatzakis E, Tsianos E.
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [Abstract] [Full Text] [Related]

  • 14. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 15. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
    Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K.
    Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA.
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [Abstract] [Full Text] [Related]

  • 17. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.
    Sreenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, Choudhuri G.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832
    [Abstract] [Full Text] [Related]

  • 18. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I, Ubaldi E, Napoli L, Marulli CF, Nebiacolombo C, Cottone C, Portincasa P.
    Ann Hepatol; 2013 Jan; 12(1):70-7. PubMed ID: 23293196
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z, Xu M, Hu Z, Shrestha UK.
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
    Pirvulescu I, Gheorghe L, Csiki I, Becheanu G, Dumbravă M, Fica S, Martin S, Sarbu A, Gheorghe C, Diculescu M, Copăescu C.
    Chirurgia (Bucur); 2012 Jun; 107(6):772-9. PubMed ID: 23294957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.